333

INNOGENE

No trades
See on Supercharts
Market capitalization
‪27.50 B‬KRW
‪1.40 B‬KRW
‪10.10 B‬KRW
‪10.40 M‬
Beta (1Y)
−0.10

About INNOGENE

CEO
Gwang-Hoon Lee
Headquarters
Seoul
Employees (FY)
58
Founded
2005
ISIN
KR7344860002
FIGI
BBG00TCNH4Z7
Innogene Co., Ltd. engages in providing anti-aging solutions through research on skin regeneration stem cells and fusion technology. Its services include medicines, scalp cares, home cares, and hair transplant. The company was founded on September 7, 2005 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 344860 is 2235 KRW — it has decreased by 2.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange INNOGENE stocks are traded under the ticker 344860.
344860 stock is 4.98% volatile and has beta coefficient of −0.10. Check out the list of the most volatile stocks — is INNOGENE there?
Yes, you can track INNOGENE financials in yearly and quarterly reports right on TradingView.
344860 stock has fallen by 6.09% compared to the previous week, the month change is a 0.89% fall, over the last year INNOGENE has showed a 43.20% decrease.
344860 net income for the last quarter is ‪436.17 M‬ KRW, while the quarter before that showed ‪343.10 M‬ KRW of net income which accounts for 27.12% change. Track more INNOGENE financial stats to get the full picture.
Today INNOGENE has the market capitalization of ‪27.44 B‬, it has decreased by 0.43% over the last week.
Yes, 344860 dividends are paid annually. The last dividend per share was 30.00 KRW. As of today, Dividend Yield (TTM)% is 1.31%. Tracking INNOGENE dividends might help you take more informed decisions.
INNOGENE dividend yield was 1.09% in 2023, and payout ratio reached 24.97%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 344860 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOGENE stock right from TradingView charts — choose your broker and connect to your account.
344860 reached its all-time high on Feb 21, 2023 with the price of 8250 KRW, and its all-time low was 2195 KRW and was reached on Mar 14, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 58.00 employees. See our rating of the largest employees — is INNOGENE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOGENE technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOGENE stock shows the neutral signal. See more of INNOGENE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOGENE EBITDA is ‪1.24 B‬ KRW, and current EBITDA margin is 14.42%. See more stats in INNOGENE financial statements.